Who mentions $ASND most on Surfaced?

@adamfeuerstein (Adam Feuerstein ✡️) mentions $ASND most — 5 mentions in the past 12 months.

When was $ASND first mentioned on Surfaced?

The earliest tracked mention of $ASND in the Surfaced archive was on Sep 22, 2025.

How many voices track $ASND?

2 FinTwit voices have mentioned $ASND 6 times in the past 12 months.

What kind of voices mention $ASND most?

$ASND is mentioned most by Biotech voices on Surfaced.

Last 12mo stats

mentions

voices

$ASND

Ascendis Pharma A/S

$ASND

Ascendis Pharma A/S

Past 12mo:6mentions2voices

All voices6 mentions since Sep 2025calls only

Loading price chart…

About this stock

$ASND received attention from 2 distinct FinTwit voices across 6 mentions over a 12-month period from September 2025 through February 2026. @adamfeuerstein (@adamfeuerstein) dominated the discussion with 5 mentions, while @investmentguru_ contributed 1 mention. The most recent activity occurred on February 27, 2026, when @adamfeuerstein posted about $ASND receiving approval following an FDA decision on Transcon CNP for children with achondroplasia, with a prior post the same day noting a trading halt ahead of that decision.

AI-generated from tracked posts · updated Jul 10, 2026

Frequently asked

Related stocks

$ALKSAlkermes

$ALMSAlumis

$ATAIATAI Life Sciences

$CMPSCompass Pathways

Recent mentions

6 mentions

@adamfeuersteinFeb 27, 2026 · 9:57 PM

$ASND approved https://t.co/lBUhOuMowI

Open on X

@adamfeuersteinFeb 27, 2026 · 9:31 PM

$ASND halted ahead of FDA decision on Transcon CNP for kids w/ achondroplasia.

Open on X

@investmentguru_Jan 6, 2026 · 12:48 AM

The Fastest Growing Companies Heading Into 2026 From AI infrastructure and space to biotech, energy, and digital assets, these companies are where real growth is showing up on the tape: Top Performers $NBIS $PTGX $FLY $MP $LUNR AI, Crypto & Infrastructure Leaders $CRWV, $WULF, $IREN, $HUT, $CORZ, $CIFR, $BTDR $NVDA still dominant $ALAB, $AAOI, $SKYT — Chips & connectivity Biotech Breakouts $INSM, $SNDX, $ZYME, $ASND, $BBIO, $AXSM, $RYTM, $MDGL Clinical wins = asymmetric upside Energy, Mining & Industrials $USAS, $ARMN, $NGD, $TLN, $MP $DQ Speculative Growth $LCID, $NIO, $LMND, $RKT — High risk, high torque Space & Defense $RKLB, $RDW, $GEMI, $CDLR — Multi-year contracts + government spend $PLTR — AI + defense + enterprise scale 2026 won’t reward diversification — it will reward conviction, timing, and theme alignment. You don’t need 40 stocks. You need 3–5 leaders in megatrend sectors — and the patience to let compounding do the work. Follow the growth, not the noise.

Open on X

@adamfeuersteinSep 22, 2025 · 7:55 PM

@avidresearch You could say the $MBX placebo response could have been wrung out by week 12, vs week 4 in the $ASND study. Onward to phase 3!

Open on X

@adamfeuersteinSep 22, 2025 · 12:02 PM

@Sanctuary_Bio Perhaps. Also, $MBX EV heading into the readout was just over $100M. $ASND is $10B.

Open on X

@adamfeuersteinSep 22, 2025 · 11:02 AM

$MBX hormone replacement shows efficacy in mid-stage study. The results, however, were less impressive when compared to an $ASND approved treatment Canvu response rate 63% vs 31% placebo, the latter is high and dims the treatment effect. https://t.co/Ey1bpu3Tfb

Open on X